This inventor holds 25 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents, primarily in Metabotropic Glutamate Receptors. Top assignees: Nps Pharmaceuticals, Inc., Astrazeneca Ab, Smithkline Beecham Corporation. Active years: 1996-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
19 out of 93 
4 out of 1,534 
3 out of 2,198 
Years Active: 1996-2012
Areas of Expertise:
Title: Innovations in Pharmacology: The Contributions of Bradford C Van Wagenen
Introduction: Bradford C Van Wagenen is a renowned inventor based in Salt Lake City, UT, with an impressive portfolio of 25 patents. His work primarily focuses on the field of pharmacology, particularly in relation to metabotropic glutamate receptor potentiation, which has significant implications for therapeutic developments.
Latest Patents: Among his latest patents are groundbreaking compounds classified as metabotropic glutamate-receptor-potentiating isoindolones. These compounds have a distinct formula that is defined in detail within the patent description. Additionally, Van Wagenen has secured patents for isoindolone compounds and their utility as metabotropic glutamate receptor potentiators, encompassing their preparation processes, new intermediates, pharmaceutical compositions, and therapeutic applications.
Career Highlights: Throughout his career, Bradford C Van Wagenen has significantly contributed to the pharmaceutical industry, working with prominent companies such as NPS Pharmaceuticals, Inc. and AstraZeneca AB. His innovative research and patents have been pivotal in advancing the understanding and treatment of various health conditions through the modulation of glutamate receptors.
Collaborations: Van Wagenen’s work has been enriched through collaborations with esteemed colleagues such as Manuel F Balandrin and Scott T Moe. Together, they have pursued research that furthers the understanding of pharmacological compounds and their therapeutic potentials.
Conclusion: Bradford C Van Wagenen's contributions to the field of pharmacology and his extensive patent portfolio demonstrate his commitment to innovation and research. His work continues to influence the development of novel therapeutic agents, making significant strides in medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile